Avedro is a commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and improving vision to reduce dependency on eyeglasses or contact lenses. Co.'s proprietary Avedro Corneal Remodeling Platform is comprised of its KXL and Mosaic systems, each of which delivers ultraviolet A light, and a suite of proprietary single-use riboflavin drug formulations, which, when applied together to the cornea, induce a biochemical reaction called corneal collagen cross-linking. Co.'s KXL system in combination with its Photrexa drug formulations is indicated for the treatment of progressive keratoconus and corneal ectasia following refractive surgery. We show 6 historical shares outstanding datapoints in our AVDR shares outstanding history coverage, used to compute AVDR market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing AVDR market cap history over the course of time is important for investors
interested in comparing AVDR's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of AVDR versus a peer is one thing; comparing
AVDR market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like AVDR can fluctuate over the course of history.
With this page we aim to empower investors researching AVDR by allowing them to research the AVDR market cap history. |
Free AVDR Email Alerts:
Video: The Importance of Market Cap
